Building a Tool to Evaluate and Improve Health Investments in Screening and Diagnosis of disease

back home
Print version Increase text Decrease text
Contract/Grant agreement number
: 223533
EC contribution
: € 438,885.00
: 24 months
Starting date
: 01/03/2009
: Genetic testing, cost-effectiveness, health technology assessment.
Project web-site
: -

Health policy decision makers and public funders are faced with the challenge of making choices for health investments to improve the healthy life expectancy of Europeans within the context of constrained resources. Health investments relate to any new technology for the diagnosis, prevention or treatment of disease.

It is not clear to which extent recent decisions on such health investments have been optimal. Public funders sometimes, but increasingly, evaluate the impact of health investments, but there is a lack of standardised procedures and criteria. This is even more the case for investments related to screening and diagnosis of disease, and in particular gene technologies.

[+] Read More